ヘリコバクター・ピロリ感染症(Helicobacter Pylori Infections)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Helicobacter Pylori Infections - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Helicobacter Pylori Infections Overview 7
Therapeutics Development 8
Pipeline Products for Helicobacter Pylori Infections – Overview 8
Pipeline Products for Helicobacter Pylori Infections – Comparative Analysis 9
Helicobacter Pylori Infections – Therapeutics under Development by Companies 10
Helicobacter Pylori Infections – Therapeutics under Investigation by Universities/Institutes 11
Helicobacter Pylori Infections – Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Helicobacter Pylori Infections – Products under Development by Companies 15
Helicobacter Pylori Infections – Products under Investigation by Universities/Institutes 16
Helicobacter Pylori Infections – Companies Involved in Therapeutics Development 17
Daewoong Pharmaceutical Co., Ltd. 17
EpiVax, Inc. 18
ImevaX GmbH 19
ImmunoBiology Ltd. 20
RedHill Biopharma Ltd. 21
Sequella, Inc. 22
Shanghai Zerun Biotechnology Co., Ltd. 23
Sigmoid Pharma Limited 24
Takeda Pharmaceutical Company Limited 25
Helicobacter Pylori Infections – Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Combination Products 27
Assessment by Target 28
Assessment by Mechanism of Action 30
Assessment by Route of Administration 32
Assessment by Molecule Type 34
Drug Profiles 36
(rifabutin + amoxicillin sodium + omeprazole) – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
DWJ-1325 – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
H.pylori vaccine – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
helicobacter pylori infection vaccine – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
helicobacter pylori vaccine – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
helicobacter pylori vaccine – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
helicobacter pylori vaccine [Hel-305] (multivalent) – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
HPi-1 – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
IMX-101 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Small Molecules for Helicobacter Pylori Infections – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
Small Molecules to Inhibit DNA Synthesis for Infectious Diseases – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
SQ-109 – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
vonoprazan – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
Helicobacter Pylori Infections – Recent Pipeline Updates 53
Helicobacter Pylori Infections – Dormant Projects 57
Helicobacter Pylori Infections – Product Development Milestones 58
Featured News & Press Releases 58
Dec 26, 2014: New Drug Application Approval of TAKECAB for the treatment of Acid-related Diseases in Japan 58
Nov 10, 2014: FDA Grants QIDP Fast-Track Designation To RedHill Biopharma’s Phase 3 H. Pylori Drug RHB-105 58
Aug 27, 2014: RedHill Biopharma Provides Update on Expansion of Ongoing RHB-105 Phase III Study, Targeting Broadened H. pylori Indication Authorized by FDA 59
Dec 23, 2013: RedHill Biopharma Reports Positive PK Results in Support of Ongoing RHB-105 Phase III H. pylori Study 61
Dec 17, 2013: RedHill Biopharma Announces First Patients Dosed in Phase III Study of RHB-105 for H. pylori Infection 62
Dec 02, 2013: ProJect Pharmaceutics and TUM-Spin-off ImevaX Announce Agreement on Development of Pharmaceutical Formulation for IMX101 63
Oct 30, 2013: RedHill Biopharma Initiates Phase III Study of RHB-105 for H. pylori Infection 64
Oct 22, 2013: RedHill Biopharma Announces FDA Acceptance of IND Application for RHB-105 Phase III Study – to Commence Shortly 65
Dec 06, 2010: Sequella Wins FDA Approval To Begin Phase II Trial Of SQ109 In Helicobacter pylori-Associated Duodenal Ulcers 66
Appendix 67
Methodology 67
Coverage 67
Secondary Research 67
Primary Research 67
Expert Panel Validation 67
Contact Us 68
Disclaimer 68


【レポート販売概要】

■ タイトル:ヘリコバクター・ピロリ感染症(Helicobacter Pylori Infections)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Helicobacter Pylori Infections - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6065IDB
■ 調査対象地域:グローバル
  • 生分解性パッケージ材料の世界市場2017-2021
    ABSTRACTAbout Biodegradable Packaging Materials Packaging includes an extensive range of materials such as paper, board, plastic, metal, glass, wood, and other materials. Biodegradable materials such as bioplastics and paper are widely used in packaging applications because of their sustainable nature, appearance, and properties. These materials are decomposed naturally by microorganisms. Biodegra …
  • 世界のエピクロルヒドリン市場
    The increasing demand of Epichlorohydrin in China and growth in the end-user segments such as paint and electronic industry are key factors to drive the global ECH market. Epoxy resin is the main application which consumes a large part of Epichlorohydrin. Properties of epoxy resin make it suitable for wide variety of applications such as paints, electrical & electronics, construction, wind turbine …
  • 脊椎インプラントおよび手術機器の世界市場予測(~2021):胸椎固定装置、腰椎固定装置、頸椎固定装置、脊椎用生物製剤、VCF治療機器、脊髄減圧、非固定装置、脊椎骨刺激器
    The global spinal implants market is estimated to reach 17.27 Billion by 2021, at a CAGR of 5.3% from 2016 to 2021. A number of factors such as technological advancements in spine surgery devices, increasing aging and obese population along with the rising incidence and prevalence of spinal disorders, and rising demand for minimally invasive spine surgery are propelling the growth of the global sp …
  • ERP(企業資源計画)のグローバル市場動向(2014-2018)
    About ERP ERP software is a business management solution that enables organizations to integrate all business operations, including product planning, product development, manufacturing processes, inventory control, and distribution for optimal management. Various modules of ERP software can be purchased as a stand-alone offering or as an embedded offering. Each of these modules pertain to one of t …
  • 2014年戦略提言:スペインの止血診断検査市場
    Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.SummaryThis comprehensive report contains 400 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years.  The report explores business and techno …
  • PerkinElmer, Inc.:市場シェア分析
    PerkinElmer, Inc. Market Share Analysis Summary GlobalData’s new report, “PerkinElmer, Inc. Market Share Analysis” provides in-depth information on PerkinElmer, Inc.’s market position in the different medical equipment markets it operates in. The report provides PerkinElmer, Inc. market share information in two key market categories – Immuno Chemistry and Infectious Immunology. The report also pro …
  • 非アルコール性脂肪性肝炎(Non-Alcoholic Steatohepatitis):世界の治験レビュー(2015年上半期版)
    Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2015" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overv …
  • 医療レポート:Nonalcoholic Steatohepatitis-疫学予測(~2022)
    EpiCast Report: Nonalcoholic Steatohepatitis - Epidemiology Forecast to 2022 Summary Nonalcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of a fatty, inflamed, and damaged liver. It resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. NASH is becoming increasingly common with the alarming epidemic of …
  • 前立腺生検の世界市場2017-2021:針生検、液体生検
    About Prostate Biopsy Market Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatment …
  • モバイルPOS端末の世界市場2015-2019
    About Mobile POS A mobile POS refers to an electronic payment system that transfers funds using credit and debit cards at POS terminals located at retail outlets. Mobile POS systems are equipped with features such as Wi-Fi, RFID, VoIP, and smart card capabilities. These systems are highly versatile and are used primarily as data devices. In addition, they are used for sending digitized notes, chec …
  • キヌア種子の世界市場2016-2020
    About Quinoa Seeds Quinoa belongs to the spinach family Chenopodium genus and is a healthy substitute to a carb- and meat-centric diet. Over the last few years, quinoa foods have emerged as a superfood in the health and wellness food category, especially in the Americas and Europe. Quinoa is the only plant food that possesses all the essential amino acids, vitamins, and trace elements. Furthermore …
  • クラウド型ビデオサービスの世界市場予測(~2021)
    MarketsandMarkets forecasts the Video-as-a-Service (VaaS) market size to grow from USD 390.3 Million in 2016 to USD 1,587.4 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 32.4% from 2016 to 2021. The increasing number of connected devices, proliferation of smartphones, rising BYOD trends, increase in the adoption of cloud services by Small and Medium Enterprises (SMEs), lower total co …
  • iPad & Social Media: A Paradigm Shift for Business
    The iPad from Apple is significantly altering the technology landscape and business practices of companies and users around the globe. While there are emerging reports on the iPad and some of its impact on business, this report is the first to evaluate the changes that the iPad in conjunction with Social Media are having on the business environment. The report includes the following: * Evaluation …
  • Worldwide Handset Shipments, Market Share & Growth Rate by Vendor, Region and Country Q3’2011
    Worldwide handset shipments reached over 393.96 million units during the third quarter of 2011, representing a Year-over-Year (YoY) growth rate of 14.86 %. While shipment volumes declined in developed markets such as North America and Western Europe, developing markets such as Asia Pacific, Latin & Central America (LACA), and Middle East & Africa (MEA) region experienced a thriving growth in shipm …
  • Cellulosic Ethanol – Global Production, Major Trends, Regulations, and Key Country Analysis to 2020
    Cellulosic Ethanol - Global Production, Major Trends, Regulations, and Key Country Analysis to 2020 Summary “Cellulosic Ethanol - Global Production, Major Trends, Regulations, and Key Country Analysis to 2020” is the latest report from industry analysis specialist GlobalData, offering comprehensive information on the global cellulosic ethanol market. The report provides a clear understanding and d …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。